Seneste diskussioner
What factors drove the 9.13% increase in institutional ownership of CRMD shares in the most recent quarter?
Why did D. Boral Capital downgrade CRMD to Hold on June 30, 2025, despite a $20.06 average price target?
How might current interest rate trends affect the $150M convertible debt financing for the Melinta acquisition?
How might future changes to the Medicare ESRD PPS or TDAPA impact DefenCath's revenue beyond July 2024 implementation?
How will the Melinta Therapeutics acquisition, announced August 7, 2025, impact CRMD's product pipeline and market strategy?
